Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...
A new care pathway has emerged in the United States, and patients are already using it every day. Direct-to-patient (DTP) platforms – defined as a digitally enabled, end-to-end treatment model in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results